TITLE: EXPLAINABLE AI IN MEDICAL IMAGING: AN OVERVIEW FOR CLINICAL

PRACTITIONERS –
BEYOND SALIENCY-BASED XAI APPROACHES

AUTHORS: BORYS K, SCHMITT YA, NAUTA M, SEIFERT C, KRÄMER N, FRIEDRICH

CM, NENSA F.
 Challenges discussed in the paper may include:

- Balancing model complexity and interpretability.

- Ensuring the fidelity of explanations provided by AI
models.
- Addressing the trade-off between accuracy and
interpretability.
Short Summary For The Solution
Approach
 The specific dataset used for fetal brain MRI
segmentation is not mentioned in the provided excerpt.
However, it is likely that the authors utilized publicly
available or institution-specific fetal brain MRI datasets
for algorithm development and validation.
 Future Plan To Execute

* Understanding user needs and expectations for explainability in

different contexts.
* Identifying suitable XAI methods for different tasks and types of
data.
* Evaluating the effectiveness of XAI methods and ensuring they are
beneficial and not misleading.

Overall, this paper provides a valuable resource for both researchers

and practitioners interested in advancing the responsible and
trustworthy use of AI in medical imaging.
TITLE: NEURONET19: AN EXPLAINABLE DEEP NEURAL NETWORK MODEL FOR THE
CLASSIFICATION OF BRAIN TUMORS USING MAGNETIC RESONANCE IMAGING
DATA.

AUTHORS: R. HAQUE, M.M. HASSAN, A.K. BAIRAGI, S.M. SHARIFUL ISLAM

 Challenges of the problem:

1. Handling the complexity and variability of brain tumor images

captured through MRI scans.
2. Ensuring the deep neural network model is robust and
generalizable across different patient demographics and imaging
conditions.
3. Providing explanations or visualizations to clinicians regarding the
decision-making process of the model.
Short Summary For The
Solution Approach
The paper likely uses a dataset of MRI scans
containing images of brain tumors and
healthy brain tissue for training and
evaluation purposes.
 Future Plan To Execute

Expanding the model's capabilities to handle different types and

stages of brain tumors.
- Improving the efficiency and scalability of the deep learning
architecture.
- Integrating additional clinical data or multimodal imaging for more
comprehensive analysis.